Literature DB >> 6826235

Biosynthesis and release of platelet-activating factor from human monocytes.

G Camussi, F Bussolino, C Tetta, W Piacibello, M Aglietta.   

Abstract

The aim of the present study was to investigate the pathways of platelet-activating factor (PAF) production and release from human monocytes. For this purpose, both phagocytic stimuli and stimuli induced by soluble agents were used. The phagocytic stimuli exerted their effect in a receptor-specific mechanism related to surface Fc, C3b and C3d receptors. Stimuli induced by soluble agents, such as A23187 and pH 10.6, which do not require interaction with specific receptors, were also effective in inducing PAF release. In contrast, C5a, a soluble agent which induces a receptor-mediated release of PAF from neutrophils, failed to induce PAF release from monocytes. PAF release from monocytes could be dissociated from phagocytosis and from release of lysozyme. The PAF release required the presence of extracellular cations, the activation of membrane esterase and phospholipase A2 and the integrity of the microfilament system. Moreover, PAF release was modulated by lipoxygenase and intracellular cAMP levels. The relevance of an acetylation process in the biosynthesis of PAF was suggested by the increase of PAF yields in the presence of sodium acetate and by the incorporation of 14C-sodium acetate into molecules of active PAF.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6826235     DOI: 10.1159/000233331

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  13 in total

1.  Role of platelet-activating factor in the reperfusion injury of rabbit ischemic heart.

Authors:  G Montrucchio; G Alloatti; F Mariano; R de Paulis; A Comino; G Emanuelli; G Camussi
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

2.  Fc receptor triggering induces expression of surface activation antigens and release of platelet-activating factor in large granular lymphocytes.

Authors:  F Malavasi; C Tetta; A Funaro; G Bellone; E Ferrero; A C Franzone; P Dellabona; R Rusci; L Matera; G Camussi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

3.  Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.

Authors:  S Takahashi; T Yoshikawa; Y Naito; T Tanigawa; N Yoshida; M Kondo
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

4.  Synergistic platelet activation by aggregates of IgG and the phospholipid platelet-activating factor 1-O-alkyl-2-acetyl-SN-glycero-3-phosphorylcholine.

Authors:  F H Valone
Journal:  J Clin Immunol       Date:  1986-01       Impact factor: 8.317

5.  Experimental acute pancreatitis induced by platelet activating factor in rabbits.

Authors:  G Emanuelli; G Montrucchio; E Gaia; L Dughera; G Corvetti; L Gubetta
Journal:  Am J Pathol       Date:  1989-02       Impact factor: 4.307

6.  A novel bioaction of PAF: induction of microbicidal activity in guinea pig bone marrow cells.

Authors:  H Hayashi; I Kudo; T Kato; R Nozawa; S Nojima; K Inoue
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

7.  Activation of human peripheral blood monocytes by lipoproteins.

Authors:  J L Kelley; M M Rozek; C A Suenram; C J Schwartz
Journal:  Am J Pathol       Date:  1988-02       Impact factor: 4.307

8.  Tiam1 and Rac1 are required for platelet-activating factor-induced endothelial junctional disassembly and increase in vascular permeability.

Authors:  Ivana I Knezevic; Sanda A Predescu; Radu F Neamu; Matvey S Gorovoy; Nebojsa M Knezevic; Cordus Easington; Asrar B Malik; Dan N Predescu
Journal:  J Biol Chem       Date:  2008-12-17       Impact factor: 5.157

9.  Effects of a platelet-activating factor antagonist, CV-6209, on gastric mucosal lesions induced by ischemia-reperfusion.

Authors:  T Yoshikawa; S Takahashi; Y Naito; S Ueda; T Tanigawa; N Yoshida; M Kondo
Journal:  Lipids       Date:  1992-12       Impact factor: 1.880

10.  Platelet activating factor-induced ceramide micro-domains drive endothelial NOS activation and contribute to barrier dysfunction.

Authors:  Sanda Predescu; Ivana Knezevic; Cristina Bardita; Radu Florin Neamu; Viktor Brovcovych; Dan Predescu
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.